We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Glycosaminoglycans Detected in Dried Urine Samples

By LabMedica International staff writers
Posted on 16 Jan 2013
Almost all patients with mucopolysaccharidoses (MPS) have increased levels of glycosaminoglycans (GAGs) in their urine, but transportation of liquid samples may be challenging. More...


As transportation of liquid urine samples in appropriate conditions for long distances, especially across international borders, could be difficult, urine samples dried onto filter paper could be a solution to the problem.

Scientists at the Portal Hospital de Clinicas (Porto Alegre, RS, Brazil) collected urine samples from untreated MPS patients and from healthy controls. Dried-urine filter paper (DUFP) were prepared with four rectangles measuring 15×40 mm of filter paper which were then completely dipped into the urine flasks for a few seconds and then dried at room temperature for at least four hours. A colorimetric method for total urinary GAG quantification was used with slight modification and is based in the reaction of GAGs with dimethylmethylene blue.

The scientists found that there were no differences in the concentration of GAGs between urine and DUFP samples Concentration of GAGs in DUFP samples of MPS patients never overlapped with that of normal controls. Untreated patients with MPS and normal controls were well discriminated using any of the samples. Creatinine concentration in liquid urine and DUFP samples was also determined and used as a correction factor. The concentration of GAG was found to be almost identical in liquid and DUFP samples in all the controls.

The authors concluded that conclude that determination of GAGs on DUFPs is comparable to the ones performed in liquid urine samples. Their incorporation by reference laboratories would provide an additional screening tool, which could be useful in particular circumstances and which could be made available along with the existing methods of GAG analysis. Handling and mailing of filter paper samples will facilitate the identification of MPS patients worldwide, especially when samples need to travel long distances and cross international borders, contributing to the earlier diagnosis and timely treatment of these diseases.

The mucopolysaccharidoses (MPS) are inherited metabolic disorders with bone, joint, and visceral abnormalities, leading to multiorgan dysfunction and, sometimes, neurological manifestations. The study was published in the January 2013 edition of the journal Clinica Chimica Acta.

Related Links:
Portal Hospital de Clinicas


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.